Examination of Nociscan Impact on Discogenic Low Back Pain Surgical Outcomes | MicrobiomeTrials← Back to trialsNCT06661850
Examination of Nociscan Impact on Discogenic Low Back Pain Surgical Outcomes
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-06-11Est. Completion: 2027-09-30
Enrollment target: 300 participants Locations- Todd H. Lanman, M.D Inc, Beverly Hills, California, United States
- Scripps Health, La Jolla, California, United States
- USC Keck Medical Center, Los Angeles, California, United States
- University of Miami/ Jackson Health System, Miami, Florida, United States
- Northwestern University, Chicago, Illinois, United States
- Endeavor Health, Evanston, Illinois, United States
- Advocate Aurora Research Institute, Park Ridge, Illinois, United States
- Johns Hopkins Medicine, Baltimore, Maryland, United States
- Texas Back Institute, Plano, Texas, United States
Other microbiome trials you might be interested in
Discogenic Low Back Pain
The pathophysiology arises from structural and biochemical degeneration within the intervertebral disc rather than direc…
Islamabad, PakistanCompleted Jun 8, 2026
Degenerative Disc Disease
The goal of this study is to evaluate the safety and tolerability of TG-C in subjects with chronic discogenic lumbar bac…
Multiple LocationsEst. completion Jul 28, 2028